JHS Svendgaard Laboratories (BOM:532771) Total Liabilities : ₹271.7 Mil (As of Mar. 2024)

View and export this data going back to 2006. Start your Free Trial

What is JHS Svendgaard Laboratories Total Liabilities?

JHS Svendgaard Laboratories's Total Liabilities for the quarter that ended in Mar. 2024 was ₹271.7 Mil.

JHS Svendgaard Laboratories's quarterly Total Liabilities declined from Sep. 2023 (₹258.97 Mil) to Dec. 2023 (₹0.00 Mil) but then increased from Dec. 2023 (₹0.00 Mil) to Mar. 2024 (₹271.71 Mil).

JHS Svendgaard Laboratories's annual Total Liabilities increased from Mar. 2022 (₹269.46 Mil) to Mar. 2023 (₹558.87 Mil) but then declined from Mar. 2023 (₹558.87 Mil) to Mar. 2024 (₹271.71 Mil).

JHS Svendgaard Laboratories Total Liabilities Historical Data

The historical data trend for JHS Svendgaard Laboratories's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

JHS Svendgaard Laboratories Total Liabilities Chart

JHS Svendgaard Laboratories Annual Data

Trend

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Mar24

Total Liabilities

Get a 7-Day Free Trial

563.20

299.97

269.46

558.87

271.71

JHS Svendgaard Laboratories Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Total Liabilities	Get a 7-Day Free Trial															558.87	-	258.97	-	271.71

JHS Svendgaard Laboratories Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

JHS Svendgaard Laboratories's Total Liabilities for the fiscal year that ended in Mar. 2024 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	233.37	+	(11.674	+	26.663
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit)
	+	0	+	0)
	=	271.7

Total Liabilities	=	Total Assets (A: Mar. 2024 )	-	Total Equity (A: Mar. 2024 )
	=	1970.546	-	1698.839
	=	271.7

JHS Svendgaard Laboratories's Total Liabilities for the quarter that ended in Mar. 2024 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	233.37	+	(11.674	+	26.663
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit)
	+	0	+	0)
	=	271.7

Total Liabilities	=	Total Assets (Q: Mar. 2024 )	-	Total Equity (Q: Mar. 2024 )
	=	1970.546	-	1698.839
	=	271.7

JHS Svendgaard Laboratories Total Liabilities Related Terms

Thank you for viewing the detailed overview of JHS Svendgaard Laboratories's Total Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

JHS Svendgaard Laboratories (BOM:532771) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Consumer Defensive » Consumer Packaged Goods » JHS Svendgaard Laboratories Ltd (BOM:532771) » Definitions » Total Liabilities

Comparable Companies

Traded in Other Exchanges

JHS:India

Address

Mathura Road, B-1/E-23, Mohan Co-operative Industrial Area, New Delhi, IND, 110044

Website

https://www.svendgaard.com

JHS Svendgaard Laboratories Ltd is a manufacturer of dental and oral care products. Its business segments include Manufacturing Business; Other than Manufacturing Business and Retail Business. Its product portfolio includes a toothbrush, toothpaste, mouthwash, laundry detergent, hand sanitizer, and room fresheners. It sells products under its own brand name and private labels including Dr. Gold, P&G, Amway, Future Group, Dabur, Elder Pharma, J. L. Morison's among others, and in the international market are - Dr. Fresh, Boots, Peanuts, and Lavoris. It generates the majority of the revenue from the Manufacturing Business segment.

JHS Svendgaard Laboratories (BOM:532771) Headlines

No Headlines